Neurobiology of Disease (Nov 2009)

Disruption of Rab11 activity in a knock-in mouse model of Huntington's disease

  • Xueyi Li,
  • Ellen Sapp,
  • Kathryn Chase,
  • Laryssa A. Comer-Tierney,
  • Nicholas Masso,
  • Jonathan Alexander,
  • Patrick Reeves,
  • Kimberly B. Kegel,
  • Antonio Valencia,
  • Miguel Esteves,
  • Neil Aronin,
  • Marian DiFiglia

Journal volume & issue
Vol. 36, no. 2
pp. 374 – 383

Abstract

Read online

The Huntington's disease (HD) mutation causes polyglutamine expansion in huntingtin (Htt) and neurodegeneration. Htt interacts with a complex containing Rab11GDP and is involved in activation of Rab11, which functions in endosomal recycling and neurite growth and long-term potentiation. Like other Rab proteins, Rab11GDP undergoes nucleotide exchange to Rab11GTP for its activation. Here we show that striatal membranes of HD140Q/140Q knock-in mice are impaired in supporting conversion of Rab11GDP to Rab11GTP. Dominant negative Rab11 expressed in the striatum and cortex of normal mice caused neuropathology and motor dysfunction, suggesting that a deficiency in Rab11 activity is pathogenic in vivo. Primary cortical neurons from HD140Q/140Q mice were delayed in recycling transferrin receptors back to the plasma membrane. Partial rescue from glutamate-induced cell death occurred in HD neurons expressing dominant active Rab11. We propose a novel mechanism of HD pathogenesis arising from diminished Rab11 activity at recycling endosomes.

Keywords